Showing 1 – 1 of 1 results
There has been recent change in the nomenclature of nonalcoholic fatty liver disease (NAFLD) to Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD). Significant advances have also happened in the field of noninvasive testing (NITs) and therapy of MASLD in the last couple of years.
